The American College of Obstetricians and Gynecologist recently published data from two North American trials on women with hypoactive sexual desire disorder.
The data shows an improvement in their low libido when a 100mg Flibanserin treatment was implemented daily for at least forty weeks. Flibanserin is a new drug developed by the German pharmaceutical company Boehringer Ingelheim.
Flibanserin has been in the development stage for several years and is currently being touted as the female Viagra thanks to four clinical studies conducted on over five thousand women around the world.
The studies show that women with female sexual dysfunction (FSD) increase their sexual satisfying experiences from three to five a month when a Flibanserin treatment is part of their daily regime.
That may not sound that impressive at first, but any increase in sexual satisfaction is a big deal when a woman is fighting the symptoms of FSD.
Boehringer plans to market Flibanserin under the brand name Girosa once the FDA approves the drug for medical use. FDA approval is almost assured based on the results of the pooled analysis of Flibanserin treatment on hypoactive sexual desire disorder in pre-menopausal women.
The Flibanserin treatment showed improved sexual activity and an increase in sexual desire in women who received the drug instead of a placebo.
Flibanserin is composed of dopamine D4 receptors and serotonin 5-HT receptor. Boehringer originally developed Flibanserin treatment for depression, but the initial trials revealed that the drug stimulated sexual fantasies and desires, although no one knows exactly how the drug interacts with the brain.
Essentially a Flibanserin treatment helps stimulate the brain by increasing dopamine and reducing serotonin.
A Flibanserin Treatment Produces Female Viagra Type Results
Male erectile dysfunction is completely different from female sexual dysfunction. Sildenafil, better known as Viagra, increases blood flow to the penis so men can engage in sexual activity.
Flibanserin treatment and therapy is non-hormonal which means the dopamine and serotonin in the formula activate sexual hormones without being synthetic versions of those hormones.
Most of the results of a Flibanserin treatment manifest after forty weeks, so Flibanserin treatment is considered a long term therapy for female sexual dysfunction issues.
The most recent clinical studies on Flibanserin treatment show that side effects like headaches, nausea, anxiety, insomnia, dizziness, and fatigue are common.
Some women say those side effects can be just as frustrating as the symptoms of FSD, but they are willing to live with them especially when their sexually satisfying experiences dramatically increase.